Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study

Thiago Cerqueira-Silva; Syed Ahmar Shah; Chris Robertson; Mauro Sanchez; Srinivasa Vittal Katikireddi; Vinicius de Araujo Oliveira; Enny S. Paixão; Igor Rudan; Juracy Bertoldo Junior; Gerson O. Penna; Neil Pearce; Guilherme Loureiro Werneck; Mauricio L. Barreto; Viviane S. Boaventura; Aziz Sheikh; Manoel Barral-Netto

doi:10.1371/journal.pmed.1004156

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study

Thiago Cerqueira-Silva, Syed Ahmar Shah, Chris Robertson, Mauro Sanchez, Srinivasa Vittal Katikireddi, Vinicius de Araujo Oliveira, Enny S. Paixão, Igor Rudan, Juracy Bertoldo Junior, Gerson O. Penna, Neil Pearce, Guilherme Loureiro Werneck, Mauricio L. Barreto, Viviane S. Boaventura, Aziz Sheikh, Manoel Barral-Netto

科研成果: 期刊稿件 › 文章 › 同行评审

8 引用（Scopus）

源语言	英语
文章编号	e1004156
期刊	PLoS Medicine
卷	20
期	1
DOI	https://doi.org/10.1371/journal.pmed.1004156
出版状态	已出版 - 1月 2023
已对外发布	是

!!!ASJC Scopus Subject Areas

一般医学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1371/journal.pmed.1004156

其它文件与链接

引用此

Cerqueira-Silva, T., Shah, S. A., Robertson, C., Sanchez, M., Katikireddi, S. V., de Araujo Oliveira, V., Paixão, E. S., Rudan, I., Junior, J. B., Penna, G. O., Pearce, N., Werneck, G. L., Barreto, M. L., Boaventura, V. S., Sheikh, A., & Barral-Netto, M. (2023). Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study. PLoS Medicine, 20(1), 文章 e1004156. https://doi.org/10.1371/journal.pmed.1004156

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study. / Cerqueira-Silva, Thiago; Shah, Syed Ahmar; Robertson, Chris 等.
在: PLoS Medicine, 卷 20, 号码 1, e1004156, 01.2023.

科研成果: 期刊稿件 › 文章 › 同行评审

Cerqueira-Silva, T, Shah, SA, Robertson, C, Sanchez, M, Katikireddi, SV, de Araujo Oliveira, V, Paixão, ES, Rudan, I, Junior, JB, Penna, GO, Pearce, N, Werneck, GL, Barreto, ML, Boaventura, VS, Sheikh, A & Barral-Netto, M 2023, 'Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study', PLoS Medicine, 卷 20, 号码 1, e1004156. https://doi.org/10.1371/journal.pmed.1004156

Cerqueira-Silva T, Shah SA, Robertson C, Sanchez M, Katikireddi SV, de Araujo Oliveira V 等. Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study. PLoS Medicine. 2023 1月;20(1):e1004156. doi: 10.1371/journal.pmed.1004156

@article{c22607cd59774c2182df1584e4c2ad06,

title = "Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study",

author = "Thiago Cerqueira-Silva and Shah, {Syed Ahmar} and Chris Robertson and Mauro Sanchez and Katikireddi, {Srinivasa Vittal} and {de Araujo Oliveira}, Vinicius and Paix{\~a}o, {Enny S.} and Igor Rudan and Junior, {Juracy Bertoldo} and Penna, {Gerson O.} and Neil Pearce and Werneck, {Guilherme Loureiro} and Barreto, {Mauricio L.} and Boaventura, {Viviane S.} and Aziz Sheikh and Manoel Barral-Netto",

note = "Publisher Copyright: Copyright: {\textcopyright} 2023 Cerqueira-Silva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2023",

month = jan,

doi = "10.1371/journal.pmed.1004156",

language = "English",

volume = "20",

journal = "PLoS Medicine",

issn = "1549-1277",

number = "1",

}

TY - JOUR

T1 - Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland

T2 - A test-negative design case–control study

AU - Cerqueira-Silva, Thiago

AU - Shah, Syed Ahmar

AU - Robertson, Chris

AU - Sanchez, Mauro

AU - Katikireddi, Srinivasa Vittal

AU - de Araujo Oliveira, Vinicius

AU - Paixão, Enny S.

AU - Rudan, Igor

AU - Junior, Juracy Bertoldo

AU - Penna, Gerson O.

AU - Pearce, Neil

AU - Werneck, Guilherme Loureiro

AU - Barreto, Mauricio L.

AU - Boaventura, Viviane S.

AU - Sheikh, Aziz

AU - Barral-Netto, Manoel

N1 - Publisher Copyright: Copyright: © 2023 Cerqueira-Silva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2023/1

Y1 - 2023/1

UR - http://www.scopus.com/inward/record.url?scp=85147047507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147047507&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1004156

DO - 10.1371/journal.pmed.1004156

M3 - Article

C2 - 36630477

AN - SCOPUS:85147047507

SN - 1549-1277

VL - 20

JO - PLoS Medicine

JF - PLoS Medicine

IS - 1

M1 - e1004156

ER -

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此